81907-61-1

Basic information

• Product Name: Ganoderic acid B
• Synonyms: Ganoderic acid B;(25R)-3β,7β-Dihydroxy-11,15,23-trioxo-5α-lanost-8-en-26-oic acid;Aids070760;Aids-070760;Lanost-8-en-26-oic acid, 3,7-dihydroxy-3,11,23-trioxo-, (7.beta.,15.alpha.,25R)-;(3beta,7beta,25R)-3,7-Dihydroxy-11,15,23-trioxo-lanost-8-en-26-oic acid;(2R,6R)-6-((3S,5R,7S,10S,13R,14R,17R)-3,7-Dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid
• CAS NO: 81907-61-1
• Molecular Formula: C30H44O7
• Molecular Weight: 516.671
• Mol File: 81907-61-1.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 688.965 °C at 760 mmHg
• Flash Point: 384.441 °C
• Appearance: /
• Density: 1.22
• Vapor Pressure: 5.74E-22mmHg at 25°C
• Refractive Index: 1.564
• Storage Temp.: -20°C Freezer
• Solubility: Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
• PKA: 4.77±0.23(Predicted)
• CAS DataBase Reference: Ganoderic acid B(CAS DataBase Reference)
• NIST Chemistry Reference: Ganoderic acid B(81907-61-1)
• EPA Substance Registry System: Ganoderic acid B(81907-61-1)

Safety Data

• Hazardous Substances Data: 81907-61-1(Hazardous Substances Data)

Usage

Description

Ganoderic acid B is a novel lanostanoid triterpene derived from the fruiting bodies of Ganoderma Lucidum mushroom, a traditional medicinal fungus with a rich history of use in Chinese medicine. Ganoderic acid B exhibits a diverse range of therapeutic properties, making it a promising candidate for various applications in modern medicine.

Uses

Used in Pharmaceutical Industry:
Ganoderic acid B is used as a therapeutic agent for its multifaceted health benefits, including anti-viral, anti-inflammatory, anti-tumor, immunity-promoting, and anti-diabetic properties. Its diverse pharmacological actions make it a valuable asset in the development of treatments for a wide array of diseases and conditions.
Used in Antiviral Applications:
Ganoderic acid B is employed as an antiviral agent, demonstrating the ability to inhibit viral replication and reduce the severity of viral infections. Its antiviral properties make it a potential candidate for the development of treatments against various viral diseases.
Used in Anti-inflammatory Applications:
As an anti-inflammatory agent, Ganoderic acid B helps to reduce inflammation and alleviate symptoms associated with inflammatory conditions. Its ability to modulate the immune response and decrease the production of pro-inflammatory mediators makes it a promising option for the treatment of chronic inflammatory diseases.
Used in Antitumor Applications:
Ganoderic acid B is used as an anti-tumor agent, exhibiting the capacity to inhibit tumor growth and induce apoptosis in cancer cells. Its potential to target multiple signaling pathways involved in cancer progression makes it a valuable compound in the development of cancer therapies.
Used in Immunity-Promoting Applications:
As an immunity-promoting agent, Ganoderic acid B helps to enhance the immune system's ability to fight off infections and diseases. Its immunomodulatory effects make it a useful component in the development of immunostimulatory therapies and supplements.
Used in Anti-diabetic Applications:
Ganoderic acid B is used as an anti-diabetic agent, showing potential to improve insulin sensitivity and regulate blood sugar levels. Its ability to modulate glucose metabolism and protect against pancreatic β-cell damage makes it a promising candidate for the development of treatments for diabetes and related metabolic disorders.

InChI:InChI=1/C30H44O7/c1-15(10-17(31)11-16(2)26(36)37)18-12-23(35)30(7)25-19(32)13-21-27(3,4)22(34)8-9-28(21,5)24(25)20(33)14-29(18,30)6/h15-16,18-19,21-22,32,34H,8-14H2,1-7H3,(H,36,37)/t15-,16-,18-,19+,21+,22+,28+,29-,30+/m1/s1